Envista Holdings Corporation $NVST Shares Sold by Pzena Investment Management LLC

Pzena Investment Management LLC cut its stake in Envista Holdings Corporation (NYSE:NVST) by 3.7% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,325,859 shares of the company’s stock after selling 89,007 shares during the period. Pzena Investment Management LLC owned approximately 1.41% of Envista worth $50,494,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of the stock. Dimensional Fund Advisors LP boosted its position in shares of Envista by 4.0% in the third quarter. Dimensional Fund Advisors LP now owns 9,537,874 shares of the company’s stock worth $194,284,000 after acquiring an additional 367,363 shares during the last quarter. Alliancebernstein L.P. boosted its position in shares of Envista by 34.0% in the second quarter. Alliancebernstein L.P. now owns 6,098,445 shares of the company’s stock worth $119,164,000 after acquiring an additional 1,547,656 shares during the last quarter. Massachusetts Financial Services Co. MA boosted its position in shares of Envista by 15.3% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 3,349,874 shares of the company’s stock worth $72,726,000 after acquiring an additional 444,725 shares during the last quarter. Deerfield Management Company L.P. boosted its position in shares of Envista by 3.5% in the third quarter. Deerfield Management Company L.P. now owns 2,294,036 shares of the company’s stock worth $46,730,000 after acquiring an additional 78,191 shares during the last quarter. Finally, Holocene Advisors LP acquired a new stake in shares of Envista in the second quarter worth approximately $43,936,000.

Envista Trading Down 0.6%

NYSE NVST opened at $23.63 on Friday. The company’s fifty day simple moving average is $25.64 and its 200-day simple moving average is $24.31. Envista Holdings Corporation has a 52 week low of $16.41 and a 52 week high of $30.42. The company has a current ratio of 2.44, a quick ratio of 2.06 and a debt-to-equity ratio of 0.47. The stock has a market cap of $3.85 billion, a P/E ratio of 57.65, a PEG ratio of 1.49 and a beta of 0.92.

Envista (NYSE:NVST) last posted its earnings results on Wednesday, May 6th. The company reported $0.36 EPS for the quarter, topping analysts’ consensus estimates of $0.31 by $0.05. Envista had a net margin of 2.41% and a return on equity of 7.11%. During the same quarter in the previous year, the company earned $0.24 EPS. The company’s quarterly revenue was up 14.4% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Equities research analysts predict that Envista Holdings Corporation will post 1.43 EPS for the current fiscal year.

Analyst Ratings Changes

NVST has been the topic of several research analyst reports. Zacks Research cut shares of Envista from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 6th. Wall Street Zen cut shares of Envista from a “strong-buy” rating to a “buy” rating in a research report on Saturday, May 9th. Weiss Ratings cut shares of Envista from a “hold (c)” rating to a “hold (c-)” rating in a research report on Monday, May 11th. Evercore reaffirmed an “outperform” rating and set a $33.00 price target on shares of Envista in a research report on Thursday, May 7th. Finally, William Blair raised shares of Envista from a “hold” rating to an “outperform” rating in a research report on Friday, February 6th. Six analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $28.83.

Envista Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.